Insider Transactions in Q1 2024 at Laboratory Corp Of America Holdings (LH)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Feb 07
2024
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,250
+5.84%
|
-
|
Feb 07
2024
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
113
-16.56%
|
$25,199
$223.71 P/Share
|
Feb 07
2024
|
Megan D. Bailey EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
291
+28.17%
|
-
|
Feb 07
2024
|
Lance Berberian EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-0.4%
|
$20,962
$223.71 P/Share
|
Feb 07
2024
|
Lance Berberian EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
353
+1.48%
|
-
|
Feb 07
2024
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
204
-0.48%
|
$45,492
$223.71 P/Share
|
Feb 07
2024
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
629
+1.46%
|
-
|
Feb 07
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
73
-1.81%
|
$16,279
$223.71 P/Share
|
Feb 07
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
224
+5.27%
|
-
|
Feb 07
2024
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
182
-1.19%
|
$40,586
$223.71 P/Share
|
Feb 07
2024
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
680
+4.21%
|
-
|
Feb 07
2024
|
Anita Z Graham EVP, CHRO |
SELL
Payment of exercise price or tax liability
|
Direct |
107
-26.82%
|
$23,861
$223.71 P/Share
|
Feb 07
2024
|
Anita Z Graham EVP, CHRO |
BUY
Exercise of conversion of derivative security
|
Direct |
369
+48.05%
|
-
|
Feb 07
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
94
-1.18%
|
$20,962
$223.71 P/Share
|
Feb 07
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
353
+4.23%
|
-
|
Feb 07
2024
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
46
-1.99%
|
$10,258
$223.71 P/Share
|
Feb 07
2024
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+5.49%
|
-
|
Feb 07
2024
|
Richelle P Parham Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+9.99%
|
-
|
Feb 07
2024
|
Kathryn E Wengel Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+29.24%
|
-
|
Feb 07
2024
|
R Sanders Williams Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+10.44%
|
-
|
Feb 07
2024
|
Dwight Gary Gilliland Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+9.8%
|
-
|
Feb 07
2024
|
Kirsten Marie Kliphouse Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+41.79%
|
-
|
Feb 07
2024
|
Garheng Kong Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+7.37%
|
-
|
Feb 07
2024
|
Peter M Neupert Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+7.35%
|
-
|
Feb 07
2024
|
Kerrii B Anderson Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+5.52%
|
-
|
Feb 07
2024
|
Jean Luc Belingard Director |
SELL
Payment of exercise price or tax liability
|
Direct |
95
-0.53%
|
$21,185
$223.71 P/Share
|
Feb 07
2024
|
Jean Luc Belingard Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+5.03%
|
-
|
Feb 07
2024
|
Jeffrey A. Davis Director |
BUY
Exercise of conversion of derivative security
|
Direct |
947
+20.74%
|
-
|
Feb 05
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
193
-2.47%
|
$42,460
$220.57 P/Share
|
Feb 02
2024
|
Peter J Wilkinson SVP, Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
45
-2.03%
|
$9,945
$221.54 P/Share
|
Feb 02
2024
|
Peter J Wilkinson SVP, Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
131
+5.58%
|
-
|
Feb 02
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
80
-2.06%
|
$17,680
$221.54 P/Share
|
Feb 02
2024
|
Amy B. Summy EVP, Chief Marketing Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
246
+5.96%
|
-
|
Feb 02
2024
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
SELL
Payment of exercise price or tax liability
|
Direct |
166
-0.8%
|
$36,686
$221.54 P/Share
|
Feb 02
2024
|
Brian J Caveney EVP, Pres of ED, CMO & CSO |
BUY
Exercise of conversion of derivative security
|
Direct |
495
+2.33%
|
-
|
Feb 02
2024
|
Lance Berberian EVP, CIO & CTO |
SELL
Payment of exercise price or tax liability
|
Direct |
89
-0.38%
|
$19,669
$221.54 P/Share
|
Feb 02
2024
|
Lance Berberian EVP, CIO & CTO |
BUY
Exercise of conversion of derivative security
|
Direct |
331
+1.41%
|
-
|
Feb 02
2024
|
Glenn A Eisenberg Executive Vice President |
SELL
Payment of exercise price or tax liability
|
Direct |
228
-0.53%
|
$50,388
$221.54 P/Share
|
Feb 02
2024
|
Glenn A Eisenberg Executive Vice President |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+1.95%
|
-
|
Feb 02
2024
|
Jonathan P. Di Vincenzo EVP, Pres, Central Labs & Intl |
SELL
Payment of exercise price or tax liability
|
Direct |
85
-2.36%
|
$18,785
$221.54 P/Share
|
Feb 02
2024
|
Jonathan P. Di Vincenzo EVP, Pres, Central Labs & Intl |
BUY
Exercise of conversion of derivative security
|
Direct |
246
+6.4%
|
-
|
Feb 02
2024
|
Adam H Schechter President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
822
-1.64%
|
$181,662
$221.54 P/Share
|
Feb 02
2024
|
Adam H Schechter President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
3,094
+5.83%
|
-
|
Feb 02
2024
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct |
132
-1.82%
|
$29,172
$221.54 P/Share
|
Feb 02
2024
|
Mark S Schroeder EVP, Pres Diagnostics & COO |
BUY
Exercise of conversion of derivative security
|
Direct |
495
+6.39%
|
-
|
Feb 02
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
71
-0.9%
|
$15,691
$221.54 P/Share
|
Feb 02
2024
|
Vaart Sandra D Van Der EVP, Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
264
+3.23%
|
-
|